NCH CyberKnife Team Awarded National Recognition

March 30, 2006 - (Naples, FL) Debra Freeman, M.D., Radiation Oncologist, David Spellberg, M.D., Urologist and MaryEllen Masterson-McGary, M.S., Medical Physicist, were awarded top honors at the annual CyberKnife user’s meeting in San Diego recently. Dr. Freeman’s presentation on the NCH Healthcare System’s protocol for early stage treatment of prostate cancer was judged best urology paper among of all those presented from this international symposium, including Stanford University.
According to John Adler, founder and developer of the CyberKnife System and Professor of Neurosurgery at Stanford University, “The prostate treatment being developed in part by Dr. Freeman and the team at the NCH Healthcare System takes maximum advantage of the CyberKnife’s unique targeting accuracy and robotic delivery system.” Adler adds, “I truly believe that the research being done in Naples is likely to give men with early stage prostate cancer an important new effective, safe, and convenient option for eradicating their tumors.”
About the NCH Healthcare System
The NCH Healthcare System is an alliance of two hospitals, rated among the top 5% in the Nation for overall clinical excellence, 500 premier doctors and a comprehensive network of affiliated health care services.
About the CyberKnife Robotic Radiosurgery System
The CyberKnife System is the world’s first and only radiosurgery system that utilizes intelligent robotics to treat tumors anywhere in the body. The CyberKnife System treats patients in single or staged (typically 2-5) sessions by delivering multiple beams of precisely directed radiation that converge upon the tumor while minimizing injury to surrounding healthy tissue. Image guidance and computer controlled robotics combine to continuously track, detect and correct for tumor and patient movements throughout the treatment with sub-millimeter accuracy. Because of this extreme precision and accuracy, no head or body frame is required.